摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2'-羟基-4‘,5'-二甲基苯乙酮 | 36436-65-4

中文名称
2'-羟基-4‘,5'-二甲基苯乙酮
中文别名
2'-羟基-4',5'-二甲基苯乙酮;2ˊ-羟基-4ˊ,5ˊ-二甲基苯乙酮;2"-羟基-4",5"-二甲基苯乙酮;4',5'-二甲基-2'-羟基苯乙酮
英文名称
2-acetyl-4,5-dimethylphenol
英文别名
2-hydroxy-4,5-dimethylacetophenone;1-(2-hydroxy-4,5-dimethylphenyl)ethanone;4,5-Dimethyl-2-hydroxyacetophenon;2'-Hydroxy-4',5'-dimethylacetophenon;2'-Hydroxy-4',5'-dimethylacetophenone
2'-羟基-4‘,5'-二甲基苯乙酮化学式
CAS
36436-65-4
化学式
C10H12O2
mdl
MFCD00002306
分子量
164.204
InChiKey
YXVSURZEXVMUAM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    69-73 °C
  • 沸点:
    144°C/18mmHg(lit.)
  • 密度:
    1.0326 (rough estimate)
  • 最大波长(λmax):
    340nm(EtOH)(lit.)
  • 稳定性/保质期:
    常规情况下不会分解,没有危险反应。

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险品标志:
    Xi
  • 安全说明:
    S26,S36/37/39
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2914501900
  • 危险性防范说明:
    P264,P280,P302+P352+P332+P313+P362+P364,P305+P351+P338+P337+P313
  • 危险性描述:
    H315,H319
  • 储存条件:
    密封、阴凉、干燥、通风保存。

SDS

SDS:9367eabae6a70e08a9c1b6bef4f6441f
查看
Name: 2-Hydroxy-4 5-Dimethylacetophenone 98% Material Safety Data Sheet
Synonym: None known
CAS: 36436-65-4
Section 1 - Chemical Product MSDS Name:2-Hydroxy-4 5-Dimethylacetophenone 98% Material Safety Data Sheet
Synonym:None known

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
36436-65-4 2-Hydroxy-4,5-Dimethylacetophenone 98 253-035-0
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. The toxicological properties of this substance have not been fully investigated.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of this substance have not been fully investigated. Can produce delayed pulmonary edema.
Chronic:
Effects may be delayed.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 36436-65-4: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystals
Color: green - pale yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 70 - 73 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H12O2
Molecular Weight: 164.20

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 36436-65-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-Hydroxy-4,5-Dimethylacetophenone - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 37/39 Wear suitable gloves and eye/face
protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 36436-65-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 36436-65-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 36436-65-4 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Vene,J. et al., Bulletin de la Societe Chimique de France, 1963, p. 1813 - 1817
    摘要:
    DOI:
  • 作为产物:
    描述:
    3,4-二甲基苯酚吡啶 、 aluminum (III) chloride 作用下, 以 二氯甲烷 为溶剂, 反应 10.0h, 生成 2'-羟基-4‘,5'-二甲基苯乙酮
    参考文献:
    名称:
    2-氧代-2H-苯并二苯并-2-H-色烯基-5-氧代-2,5-二氢呋喃-3-羧酸酯的合成及抗炎活性。
    摘要:
    4-氯-2-氧代-2 H-亚甲基-3-甲醛(3a-g)和4-氯-2 H-亚甲基-3-甲醛(7a-h)与活化炔烃(4a-b)的环加成反应提供了2-oxo-2 H -chromenyl-5-oxo-2,5-dihydrofuran-3-羧酸盐(5a-n)和2 H -chromenyl-5-oxo-2,5-dihydrofuran-3-羧酸盐(8a -p)。筛选所有制备的化合物的抗炎活性。体外抗炎活性数据表明化合物5g,5i,5k-1和8f与标准化合物泼尼松龙(0.033±0.002 µM)相比,被测化合物对TNF-α(1.108±0.002,0.423±0.022,0.047±0.001,0.070±0.002和0.142±0.001 µM)有效。根据体外结果,已选择了三种化合物(5i,5k和8f)用于体内实验,在LPS诱导的小鼠模型中,就抗炎活性而言,这些化合物被确定为更好的化合物。化合物5
    DOI:
    10.1016/j.bmcl.2020.127341
点击查看最新优质反应信息

文献信息

  • Novel resveratrol-based flavonol derivatives: Synthesis and anti-inflammatory activity in vitro and in vivo
    作者:Liu Zeng Chen、Li Yao、Ming Ming Jiao、Jing Bo Shi、Yue Tan、Ban Feng Ruan、Xin Hua Liu
    DOI:10.1016/j.ejmech.2019.05.004
    日期:2019.8
    In order to discover novel anti-inflammatory agents, total thirty-seven new resveratrol-based flavonol derivatives were designed and synthesized. All compounds have been screened for their anti-inflammatory activity by evaluating their inhibition effect of LPS-induced NO production in RAW 264.7 macrophages. Their toxicity was also assessed in vitro. Structure-activity relationships (SARs) have been
    为了发现新的抗炎药,设计并合成了总共三十七种新的基于白藜芦醇的黄酮醇衍生物。通过评估其对RAW 264.7巨噬细胞中LPS诱导的NO生成的抑制作用,筛选了所有化合物的抗炎活性。他们的毒性也进行了体外评估。总结了结构-活性关系(SAR),最后发现2-(2,4-二甲氧基-6-(4-甲氧基苯乙烯基)苯基)-3-羟基-4H-铬-4-基团最活跃低毒的脚手架。该化合物可通过IC 50显着降低NO,IL-6和TNF-α的产生在RAW 264.7巨噬细胞中分别为1.35、1.12和1.92μM。初步的机制研究表明,它可以抑制TLR4蛋白的表达,从而激活NF-ĸB细胞信号通路。该化合物的体内抗炎活性可以通过LPS诱导的急性肺损伤(ALI)小鼠模型减轻肺部炎症。我们相信这些发现将进一步支持更有效的急性肺损伤调节抑制剂合理设计的研究。
  • Exploration of synthetic antioxidant flavonoid analogs as acetylcholinesterase inhibitors: an approach towards finding their quantitative structure–activity relationship
    作者:Abhijit Karmakar、Pravin Ambure、Tamanna Mallick、Sreeparna Das、Kunal Roy、Naznin Ara Begum
    DOI:10.1007/s00044-019-02330-8
    日期:2019.5
    acetylcholinesterase (AChE) and a series of antioxidant flavonoid analogs were studied by fluorescence spectroscopic assay. The present study incorporated different classes of naturally occurring and synthetic flavonoid compounds like flavones, isoflavones, and chalcones as well as a few standard antioxidants. The AChE inhibitory (AChEI) activity of these compounds was further analyzed using in silico techniques
    通过荧光光谱法研究了乙酰胆碱酯酶(AChE)与一系列抗氧化剂类黄酮类似物之间的结合相互作用。本研究纳入了不同种类的天然和合成类黄酮化合物,例如黄酮,异黄酮和查耳酮以及一些标准的抗氧化剂。使用计算机技术进一步分析了这些化合物的AChE抑制(AChEI)活性,即药效团作图,定量构效关系(QSAR)分析和分子对接研究。我们还比较了这些化合物的AChE抑制和自由基清除抗氧化活性。这些化合物的AChE抑制和抗氧化活性都高度依赖于其结构模式。但是,据观察,一般而言,
  • Ruthenium(II)-Catalyzed Synthesis of Spirobenzofuranones by a Decarbonylative Annulation Reaction
    作者:Partha P. Kaishap、Gauri Duarah、Bipul Sarma、Dipak Chetia、Sanjib Gogoi
    DOI:10.1002/anie.201710049
    日期:2018.1.8
    activation of six‐membered compounds is reported. The Ru‐catalyzed reaction of 3‐hydroxy‐2‐phenyl‐chromones with alkynes works most efficiently in the presence of the ligand PPh3 to provide spiro‐indenebenzofuranones. Unlike previously reported metal‐catalyzed decarbonylative annulation reactions, in the present decarbonylative annulation reaction, the annulation occurs before extrusion of carbon monoxide
    据报道,炔烃通过六元化合物的C / H / C-C活化而首次脱羰基插入。在配体PPh 3存在下,Ru-催化的3-羟基-2-苯基色酮与炔烃的反应最有效,可提供螺茚二苯并呋喃酮。与以前报道的金属催化的脱羰环化反应不同,在本脱羰环化反应中,环化发生在一氧化碳挤出之前。
  • A Facile and General Approach to 3-((Trifluoromethyl)thio)-4<i>H</i>-chromen-4-one
    作者:Haoyue Xiang、Chunhao Yang
    DOI:10.1021/ol502751k
    日期:2014.11.7
    A facile and efficient synthetic strategy to 3-((trifluoromethyl)thio)-4H-chromen-4-one was developed. AgSCF3 and trichloroisocyanuric acid were employed here to generate active electrophilic trifluoromethylthio species in situ. This reaction could proceed under mild conditions in a short reaction time and be insensitive to air and moisture.
    开发了一种简便有效的合成3-((三氟甲基)硫代)-4 H -chromen-4-one的策略。这里使用AgSCF 3和三氯异氰尿酸原位产生活性的亲电子三氟甲硫基物质。该反应可在温和的条件下在短的反应时间内进行,并且对空气和湿气不敏感。
  • [EN] SUBSTITUTED CYCLOLAKYLS AS MODULATORS OF THE INTEGRATED STRESS PATHWAY<br/>[FR] CYCLOLALKYLES SUBSTITUÉS EN TANT QUE MODULATEURS DE LA VOIE DE STRESS INTÉGRÉE
    申请人:CALICO LIFE SCIENCES LLC
    公开号:WO2020223536A1
    公开(公告)日:2020-11-05
    Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases, disorders and conditions.
    本文提供了用于调节综合应激反应(ISR)并治疗相关疾病、疾病和症状的化合物、组合物和方法。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
hnmr
mass
cnmr
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台